WAVE LIFE SCIENCES LTD. Shares Outstanding (Cover Page)
WAVE LIFE SCIENCES LTD. (WVE) had Shares Outstanding (Cover Page) of 197.05 million shares as of 2026-07-23, per its 10-Q filed 2026-07-30.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-07-30
- 2026-07-23: Entity Common Stock, Shares Outstanding 197.05M shares.
- 2026-04-22: Entity Common Stock, Shares Outstanding 192.38M shares.
- 2026-04-07: Entity Common Stock, Shares Outstanding 192.35M shares.
- 2026-02-19: Entity Common Stock, Shares Outstanding 188.25M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-23 | 197.05M shares 10-Q · filed 2026-07-30 |
| 2026-04-22 | 192.38M shares 10-Q · filed 2026-04-28 |
| 2026-04-07 | 192.35M shares 10-K/A · filed 2026-04-30 |
| 2026-02-19 | 188.25M shares 10-K · filed 2026-02-26 |
| 2025-11-07 | 167.18M shares 10-Q · filed 2025-11-10 |
| 2025-07-24 | 159.14M shares 10-Q · filed 2025-07-30 |
| 2025-05-02 | 154.13M shares 10-Q · filed 2025-05-08 |
| 2025-03-31 | 154.09M shares 10-K/A · filed 2025-04-29 |
| 2025-02-24 | 153.49M shares 10-K · filed 2025-03-04 |
| 2024-11-07 | 152.52M shares 10-Q · filed 2024-11-12 |
| 2024-08-07 | 124.74M shares 10-Q · filed 2024-08-08 |
| 2024-05-07 | 122.46M shares 10-Q · filed 2024-05-10 |
| 2024-03-27 | 122.32M shares 10-K/A · filed 2024-04-29 |
| 2024-02-28 | 122.28M shares 10-K · filed 2024-03-06 |
| 2023-11-01 | 99.05M shares 10-Q · filed 2023-11-09 |
| 2023-07-27 | 98.98M shares 10-Q · filed 2023-08-03 |
| 2023-04-25 | 98.37M shares 10-Q · filed 2023-05-03 |
| 2023-03-24 | 98.10M shares 10-K/A · filed 2023-05-05 |
| 2023-03-10 | 98.10M shares 10-K · filed 2023-03-23 |
| 2022-11-01 | 86.90M shares 10-Q · filed 2022-11-10 |
| 2022-08-03 | 86.82M shares 10-Q · filed 2022-08-11 |
| 2022-05-09 | 61.25M shares 10-Q · filed 2022-05-12 |
| 2022-03-25 | 60.86M shares 10-K/A · filed 2022-04-28 |
| 2022-02-25 | 60.84M shares 10-K · filed 2022-03-03 |
| 2021-11-01 | 58.83M shares 10-Q · filed 2021-11-10 |
| 2021-07-29 | 50.77M shares 10-Q · filed 2021-08-05 |
| 2021-05-05 | 49.86M shares 10-Q · filed 2021-05-13 |
| 2021-04-10 | 49.86M shares 10-K/A · filed 2021-04-30 |
| 2021-02-22 | 49.00M shares 10-K · filed 2021-03-04 |
| 2020-11-01 | 48.78M shares 10-Q · filed 2020-11-09 |
| 2020-08-01 | 36.45M shares 10-Q · filed 2020-08-10 |
| 2020-05-01 | 34.89M shares 10-Q · filed 2020-05-11 |
| 2020-04-10 | 34.69M shares 10-K/A · filed 2020-04-29 |
| 2020-02-21 | 34.54M shares 10-K · filed 2020-03-02 |
| 2019-11-01 | 34.29M shares 10-Q · filed 2019-11-05 |
| 2019-08-01 | 34.28M shares 10-Q · filed 2019-08-06 |
| 2019-05-01 | 34.26M shares 10-Q · filed 2019-05-10 |
| 2019-02-26 | 34.19M shares 10-K · filed 2019-03-01 |
| 2018-11-01 | 29.46M shares 10-Q · filed 2018-11-09 |
| 2018-08-01 | 29.32M shares 10-Q · filed 2018-08-09 |
| 2018-05-01 | 29.11M shares 10-Q · filed 2018-05-09 |
| 2018-03-01 | 27.99M shares 10-K · filed 2018-03-12 |
| 2017-11-01 | 27.79M shares 10-Q · filed 2017-11-09 |
| 2017-08-01 | 27.76M shares 10-Q · filed 2017-08-09 |
| 2017-05-01 | 27.72M shares 10-Q · filed 2017-05-10 |
| 2017-03-01 | 23.54M shares 10-K · filed 2017-03-16 |
| 2016-11-01 | 23.48M shares 10-Q · filed 2016-11-09 |
| 2016-08-01 | 23.44M shares 10-Q · filed 2016-08-15 |
| 2016-05-09 | 23.43M shares 10-Q · filed 2016-05-16 |
| 2016-03-25 | 21.55M shares 10-K · filed 2016-03-30 |
| 2015-12-17 | 21.55M shares 10-Q · filed 2015-12-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |